Do Not Do Recommendation
Do not offer Sativex to treat spasticity in people with MS because it is not a cost effective treatment.
Do Not Do Recommendation Details
- Do not offer Sativex to treat spasticity in people with MS because it is not a cost effective treatment.
- Sativex treatment
Source guidance details
- Multiple sclerosis: management of multiple sclerosis in primary and secondary care (CG186)
- Published date:
- October 2014
- Paragraph number:
- Page number:
View all NICE do not do from this Guidance
- Do not diagnose MS on the basis of MRI findings alone.
- Do not use vitamin B12 injections to treat fatigue in people with MS.
- Do not use fampridine to treat lack of mobility in people with MS because it is not a cost effective treatment.
- Do not routinely diagnose a relapse of MS if symptoms are present for more than 3 months.
- Do not prescribe steroids at lower doses than methylprednisolone 0.5 g daily for 5 days to treat an acute relapse of MS.
- Do not give people with MS a supply of steroids to self-administer at home for future relapses.
- Do not offer vitamin D solely for the purpose of treating MS.
- Do not offer omega-3 or omega-6 fatty acid compounds to treat MS. Explain that there is no evidence that they affect relapse frequency or progression of MS.